BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sugita E, Hayashi K, Hishikawa A, Itoh H. Epigenetic Alterations in Podocytes in Diabetic Nephropathy. Front Pharmacol 2021;12:759299. [PMID: 34630127 DOI: 10.3389/fphar.2021.759299] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Pillai A, Fulmali D. A Narrative Review of New Treatment Options for Diabetic Nephropathy. Cureus 2023;15:e33235. [PMID: 36733548 DOI: 10.7759/cureus.33235] [Reference Citation Analysis]
2 Heyman SN, Raz I, Dwyer JP, Weinberg Sibony R, Lewis JB, Abassi Z. Diabetic Proteinuria Revisited: Updated Physiologic Perspectives. Cells 2022;11:2917. [PMID: 36139492 DOI: 10.3390/cells11182917] [Reference Citation Analysis]
3 Wang X, Liu X, Jiang L, Huang Y, Zeng H, Zhu Q, Qi X, Wu Y. Paeoniflorin directly binds to TNFR1 to regulate podocyte necroptosis in diabetic kidney disease. Front Pharmacol 2022;13:966645. [DOI: 10.3389/fphar.2022.966645] [Reference Citation Analysis]
4 Shao Y, Giustarini D. Bibliometric Study of Trends in the Diabetic Nephropathy Research Space from 2016 to 2020. Oxidative Medicine and Cellular Longevity 2022;2022:1-12. [DOI: 10.1155/2022/8050137] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]